Material number |
Category | Name | Function | Intellectual property rights |
Price | Order or Joint Research Request |
---|---|---|---|---|---|---|
KYU QM2019-0123 |
Gene / Protein (derived from animal) |
Human CDCA7 promoter P3 | Human CDCA7 promoter for luciferase assay | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0122 |
Gene / Protein (derived from animal) |
Human CDCA7 promoter P2 | Human CDCA7 promoter for luciferase assay | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0121 |
Gene / Protein (derived from animal) |
Human CDCA7 promoter P1 | Human CDCA7 promoter for luciferase assay | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0101 |
Human Tissue (tissue) |
human breast cancer tissue | Development of prognostic in vitro device for patients with early breast cancer | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0098 |
Animal and Cell line from human (animal) |
p55 (Silkworm) | Classification by phenotype: local cultivar (landrace)(p) Main phenotype: N4 strain (originates from the F1 of an European race and a Southeast Asian race) Background: egg/non-diapauseV3, larva/pY, pupa(cocoon)/yellow cocoon YC Notes: Easy rearing on artificial diet | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0083 |
Human Tissue (Cell strain) |
LNCaP, LNCaP/DTX, LNCaP/CBZ, LNCaP/MDV, C4-2, C4-2/DTX, C4-2/MDV, 22Rv1, 22Rv1/DTX, 22Rv1/CBZ, 22Rv1/MDV | Drug resistant prostate cancer cell line | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0074 |
Gene / Protein (derived from bacterium) |
pSix3; silica-inducible vector for Thermus | Expression vector for Thermus thermophilus. Target gene can be expressed by the addition of super-saturated silicic acids. | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0053 |
Microbe (prokaryote (including bacterium and archaeon)) |
Bacillus cereus cereulide producer 14 strains | Cereulide producer | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0037 |
Gene / Protein (derived from animal) |
Ku80 px330 | Genome editing | None |
Academia: Cost of transaction Company: Negotiable |
|
KYU QM2019-0036 |
Gene / Protein (derived from animal) |
HELLS px330 | Genome editing | None |
Academia: Cost of transaction Company: Negotiable |
|
|< < 11 12 13 14 15 16 17 18 19 20 > >| |
Links